Shanghai researchers have devised a revolutionary, non-invasive method to monitor blood glucose, allowing for accurate blood ...

U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...

Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy doubled in the fourth quarter, but the Danish ...

A 54-year-old man in Rotterdam, Netherlands. The symptoms: The patient visited the emergency room after experiencing ...

Glucotrack (GCTK) reports successful completion of first human clinical study for continuous blood glucose monitoring, shares ...

RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ: GCTK), a medical technology company, announced the successful completion of its first in human clinical study for a novel continuous glucose monitoring ...

This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...

Wake Forest University School of Medicine researchers found that just 3½ years of intensive blood pressure control can ...

A new review found as many as 45% of Type 2 diabetics are suffering multiple deficiencies in vitamins, minerals and ...

Another claim that has sometimes been made about fizzy water in the media and in other studies (though not by the author of ...